BrightSpring Health Services (BTSG) Projected to Post Quarterly Earnings on Friday

Key Points

• BrightSpring Health Services is projected to announce its Q3 2025 earnings on October 31, expecting earnings of $0.28 per share and revenue of $3.1653 billion.
• The company's stock has seen a 1.7% increase recently, with analysts maintaining a consensus rating of "Moderate Buy" and a price target averaging $32.56.
• Insider selling activity was reported, with significant sales including Lisa A. Nalley selling 20,000 shares and Jon B. Rousseau selling 235,000 shares, both at an average price of $28.78.

BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) is expected to issue its Q3 2025 results before the market opens on Friday, October 31st. Analysts expect the company to announce earnings of $0.28 per share and revenue of $3.1653 billion for the quarter. BrightSpring Health Services has set its Q3 2025 guidance at 0.300-0.300 EPS. FY 2025 guidance at EPS.Parties can find conference call details on the company's upcoming Q3 2025 earningreport page for the latest details on the call scheduled for Tuesday, October 28, 2025 at 4:30 PM ET.

BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last announced its earnings results on Monday, October 20th. The company reported $0.30 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.03. BrightSpring Health Services had a return on equity of 11.83% and a net margin of 1.04%.The business had revenue of $3.33 billion during the quarter, compared to the consensus estimate of $3.16 billion. On average, analysts expect BrightSpring Health Services to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

BrightSpring Health Services Stock Up 1.7%

Shares of BTSG opened at $33.50 on Friday. The company has a debt-to-equity ratio of 1.43, a quick ratio of 1.34 and a current ratio of 1.76. BrightSpring Health Services has a one year low of $14.73 and a one year high of $33.87. The stock has a market capitalization of $6.07 billion, a price-to-earnings ratio of 54.92, a PEG ratio of 0.56 and a beta of 2.40. The stock has a 50 day moving average price of $27.09 and a 200 day moving average price of $23.06.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on BTSG. Morgan Stanley boosted their price target on BrightSpring Health Services from $25.00 to $32.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 14th. Mizuho boosted their price target on BrightSpring Health Services from $26.00 to $32.00 and gave the stock an "outperform" rating in a research report on Friday, October 17th. UBS Group boosted their price target on BrightSpring Health Services from $31.00 to $35.00 and gave the stock a "buy" rating in a research report on Monday, October 13th. Weiss Ratings reiterated a "hold (c-)" rating on shares of BrightSpring Health Services in a research report on Wednesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft set a $30.00 price target on BrightSpring Health Services and gave the stock a "buy" rating in a research report on Monday, September 8th. Ten investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to MarketBeat.com, BrightSpring Health Services has a consensus rating of "Moderate Buy" and a consensus price target of $32.56.

Insider Buying and Selling at BrightSpring Health Services

In other BrightSpring Health Services news, insider Lisa A. Nalley sold 20,000 shares of the company's stock in a transaction on Wednesday, October 22nd. The stock was sold at an average price of $28.78, for a total value of $575,600.00. Following the completion of the sale, the insider directly owned 131,150 shares in the company, valued at $3,774,497. This represents a 13.23% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jon B. Rousseau sold 235,000 shares of the company's stock in a transaction on Wednesday, October 22nd. The shares were sold at an average price of $28.78, for a total value of $6,763,300.00. Following the completion of the sale, the insider owned 1,131,930 shares of the company's stock, valued at approximately $32,576,945.40. The trade was a 17.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.40% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On BrightSpring Health Services

A number of hedge funds have recently modified their holdings of BTSG. EverSource Wealth Advisors LLC purchased a new position in shares of BrightSpring Health Services during the 2nd quarter worth $43,000. Sandia Investment Management LP purchased a new position in shares of BrightSpring Health Services during the 2nd quarter worth $118,000. Jump Financial LLC purchased a new position in shares of BrightSpring Health Services during the 2nd quarter worth $257,000. AQR Capital Management LLC purchased a new position in shares of BrightSpring Health Services during the 1st quarter worth $276,000. Finally, Brevan Howard Capital Management LP purchased a new position in shares of BrightSpring Health Services during the 2nd quarter worth $295,000.

About BrightSpring Health Services

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.